Henry Schein, Inc. (NASDAQ:HSIC) Receives $76.67 Consensus Target Price from Analysts

Henry Schein, Inc. (NASDAQ:HSIC) has been given a consensus rating of “Hold” by the thirteen research firms that are presently covering the stock, MarketBeat.com reports. Eight research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $76.6667.

HSIC has been the subject of several research analyst reports. Robert W. Baird reissued a “neutral” rating and issued a $72.00 price target (down previously from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Barrington Research reissued an “outperform” rating and issued a $78.00 price target on shares of Henry Schein in a report on Tuesday, September 23rd. Baird R W lowered shares of Henry Schein from a “strong-buy” rating to a “hold” rating in a report on Monday, July 14th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $75.00 price objective (down from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Finally, Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research report on Monday, July 14th.

Institutional Investors Weigh In On Henry Schein

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Personalized Indexing Management LLC lifted its position in Henry Schein by 3.5% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 4,669 shares of the company’s stock worth $341,000 after buying an additional 157 shares in the last quarter. Equitable Trust Co. lifted its position in Henry Schein by 3.1% during the 2nd quarter. Equitable Trust Co. now owns 5,317 shares of the company’s stock worth $388,000 after buying an additional 158 shares in the last quarter. CW Advisors LLC lifted its position in Henry Schein by 2.8% during the 2nd quarter. CW Advisors LLC now owns 5,913 shares of the company’s stock worth $432,000 after buying an additional 163 shares in the last quarter. TD Asset Management Inc lifted its position in Henry Schein by 0.8% during the 2nd quarter. TD Asset Management Inc now owns 22,016 shares of the company’s stock worth $1,608,000 after buying an additional 164 shares in the last quarter. Finally, Radnor Capital Management LLC lifted its position in Henry Schein by 1.6% during the 2nd quarter. Radnor Capital Management LLC now owns 11,415 shares of the company’s stock worth $834,000 after buying an additional 180 shares in the last quarter. 96.62% of the stock is owned by institutional investors.

Henry Schein Price Performance

Shares of HSIC stock opened at $63.25 on Monday. Henry Schein has a 12-month low of $60.56 and a 12-month high of $82.49. The firm has a market capitalization of $7.67 billion, a price-to-earnings ratio of 20.40, a price-to-earnings-growth ratio of 2.09 and a beta of 0.81. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. The firm has a fifty day moving average of $67.25 and a 200-day moving average of $68.68.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. During the same period last year, the firm earned $1.23 EPS. Henry Schein’s quarterly revenue was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, equities research analysts forecast that Henry Schein will post 4.74 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.